All questionsPharmacology: Wegovy (semaglutide), all indications5 questions · 2 sourcesMechanismHow does Wegovy work for weight loss (mechanism of action)?“Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1. GLP-1 is a physiological regulator of appetite and caloric intake, and the GLP-1 receptor is present in several areas of the brain involved in appetite regulation. Animal studies show that semaglutide distributed to and activated neurons in brain regions involved in regulation of food intake.” (opens the source at this quote in a new tab)CopyFlag“Semaglutide decreases calorie intake. The effects are likely mediated by affecting appetite.” (opens the source at this quote in a new tab)CopyFlag“Semaglutide delays gastric emptying.” (opens the source at this quote in a new tab)CopyFlag“The effect of Wegovy® was studied in animal models. The impact of Wegovy® in the brain is not fully understood.” (opens the source at this quote in a new tab)CopyFlagDoes Wegovy cause more fat loss than muscle (lean mass) loss?“Semaglutide lowers body weight with greater fat mass loss than lean mass loss.” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow long does Wegovy stay in your system (half-life)?“With an elimination half-life of approximately 1 week, semaglutide will be present in the circulation for about 5 to 7 weeks after the last injectable dose of 2.4 mg or 7.2 mg or oral dose of 25 mg.” (opens the source at this quote in a new tab)CopyFlagHow is Wegovy metabolized and eliminated?“Metabolism: The primary route of elimination for semaglutide is metabolism following proteolytic cleavage of the peptide backbone and sequential beta-oxidation of the fatty acid sidechain. Excretion: The primary excretion routes of semaglutide-related material are via the urine and feces. Approximately 3% of the dose is excreted in the urine as intact semaglutide.” (opens the source at this quote in a new tab)CopyFlagComponentsWhat are the inactive ingredients in Wegovy?“Each 1 mL of WEGOVY® contains the following inactive ingredients: disodium phosphate dihydrate, 1.42 mg; sodium chloride, 8.25 mg; and water for injection. WEGOVY® has a pH of approximately 7.4. Hydrochloric acid or sodium hydroxide may be added to adjust pH. Each 3 mL prefilled single-patient-use pen contains semaglutide 9.6 mg (3.2 mg/mL), which provides 4 doses of 2.4 mg semaglutide per 0.75 mL. Each 1 mL of WEGOVY® FlexTouch® solution also contains the following inactive ingredients: disodium phosphate dihydrate, 1.42 mg; phenol, 5.5 mg; propylene glycol, 14 mg; and water for injections. WEGOVY® has a pH of approximately 7.4. Hydrochloric acid or sodium hydroxide may be added to adjust pH. Each single-patient-use WEGOVY® FlexTouch® Pen contains additional volume to allow for device priming. WEGOVY® tablets include semaglutide as a white to almost white hygroscopic powder. Each tablet of WEGOVY® contains 1.5 mg, 4 mg, 9 mg or 25 mg of semaglutide and the following inactive ingredients: magnesium stearate and salcaprozate sodium (SNAC).” (opens the source at this quote in a new tab)CopyFlag